BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28035683)

  • 1. Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation.
    De Smet F; Saiz Rubio M; Hompes D; Naus E; De Baets G; Langenberg T; Hipp MS; Houben B; Claes F; Charbonneau S; Delgado Blanco J; Plaisance S; Ramkissoon S; Ramkissoon L; Simons C; van den Brandt P; Weijenberg M; Van England M; Lambrechts S; Amant F; D'Hoore A; Ligon KL; Sagaert X; Schymkowitz J; Rousseau F
    J Pathol; 2017 May; 242(1):24-38. PubMed ID: 28035683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lys-Specific Molecular Tweezer, CLR01, Modulates Aggregation of the Mutant p53 DNA Binding Domain and Inhibits Its Toxicity.
    Herzog G; Shmueli MD; Levy L; Engel L; Gazit E; Klärner FG; Schrader T; Bitan G; Segal D
    Biochemistry; 2015 Jun; 54(24):3729-38. PubMed ID: 26030124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
    Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
    Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulnerability of newly synthesized proteins to proteostasis stress.
    Xu G; Pattamatta A; Hildago R; Pace MC; Brown H; Borchelt DR
    J Cell Sci; 2016 May; 129(9):1892-901. PubMed ID: 27026526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein aggregation promotes platinum resistance in ovarian cancer.
    Yang-Hartwich Y; Soteras MG; Lin ZP; Holmberg J; Sumi N; Craveiro V; Liang M; Romanoff E; Bingham J; Garofalo F; Alvero A; Mor G
    Oncogene; 2015 Jul; 34(27):3605-16. PubMed ID: 25263447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation.
    Naus E; Derweduwe M; Lampi Y; Claeys A; Pauwels J; Langenberg T; Claes F; Xu J; Haemels V; Atak ZK; van der Kant R; Van Durme J; De Baets G; Ligon KL; Fiers M; Gevaert K; Aerts S; Rousseau F; Schymkowitz J; De Smet F
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.
    Palanikumar L; Karpauskaite L; Al-Sayegh M; Chehade I; Alam M; Hassan S; Maity D; Ali L; Kalmouni M; Hunashal Y; Ahmed J; Houhou T; Karapetyan S; Falls Z; Samudrala R; Pasricha R; Esposito G; Afzal AJ; Hamilton AD; Kumar S; Magzoub M
    Nat Commun; 2021 Jun; 12(1):3962. PubMed ID: 34172723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM4 is a rational target for treating breast cancers with mutant p53.
    Miranda PJ; Buckley D; Raghu D; Pang JB; Takano EA; Vijayakumaran R; Teunisse AF; Posner A; Procter T; Herold MJ; Gamell C; Marine JC; Fox SB; Jochemsen A; Haupt S; Haupt Y
    J Pathol; 2017 Apr; 241(5):661-670. PubMed ID: 28097652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer.
    Yamada H; Shinmura K; Yamamura Y; Kurachi K; Nakamura T; Tsuneyoshi T; Yokota N; Maekawa M; Sugimura H
    Int J Cancer; 2009 Aug; 125(4):973-6. PubMed ID: 19405127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.
    Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
    Swamy MV; Herzog CR; Rao CV
    Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [p53: an important or most overvalued tumor gene?].
    Schlegel U
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L; Gao YS; Sztul E
    Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyarginine and its analogues inhibit p53 mutant aggregation and cancer cell proliferation in vitro.
    Chen Z; Chen J; Keshamouni VG; Kanapathipillai M
    Biochem Biophys Res Commun; 2017 Jul; 489(2):130-134. PubMed ID: 28536076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSC73 in human glioblastoma cell lines.
    Matsumoto H; Shimura M; Omatsu T; Okaichi K; Majima H; Ohnishi T
    Cancer Lett; 1994 Nov; 87(1):39-46. PubMed ID: 7954368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis.
    Xiong S; Pant V; Zhang Y; Aryal NK; You MJ; Kusewitt D; Lozano G
    J Pathol; 2017 Mar; 241(4):501-510. PubMed ID: 27925213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.